EXPERIMENTAL THERAPEUTICS IN MOUSE MODELS OF MYOTONIC DYSTROPHY
EXPERIMENTAL THERAPEUTICS IN MOUSE MODELS OF MYOTONIC DYSTROPHY
批准号:
8120432
负责人:
Thurman M Wheeler
金额:
$16.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-30 至 2013-08-31
关键词:
AddressAreaAwardBasic ScienceBiotechnologyCAG repeatCalciumCell NucleusCellsClinicalClinical SciencesCytoplasmDefectDevelopmentDiseaseDoseEnvironmentFellowshipFunctional disorderGeneticGoalsHistopathologyImageIndividualInvestigationLuciferasesMechanical StressMediatingMentorsMessenger RNAModelingMolecularMolecular GeneticsMusMuscleMuscle FibersMutant Strains MiceMyopathyMyotoniaMyotonic DystrophyNeurologyNeuromuscular DiseasesNuclear RNAOligonucleotidesOutcomePathogenesisPatientsPhenotypePhysiciansPhysiologyPre-Clinical ModelPrincipal InvestigatorProceduresProcessPropertyProteinsRNARNA SplicingRNA-Binding ProteinsRNA-Protein InteractionRelative (related person)ReporterReportingResearch PersonnelResidenciesRoleRouteScheduleScientistSkeletal MuscleTherapeuticTherapeutic AgentsTherapeutic EffectTherapeutic InterventionTherapeutic UsesThinkingToxic effectTrainingTraining ProgramsTransgenic MiceTranslatingTranslational ResearchTranslationsTreatment EfficacyUniversitiesUrsidae Familybasecareercost effectivedesignexperiencegene therapyin vivoinsightmanminimally invasivemouse modelmuscle degenerationmutantnovelnovel strategiesnovel therapeuticspreventprogramsskillssmall moleculesymptom managementtherapeutic targettreatment effect
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal describes a 5-year program for training in translational research and experimental therapeutics of neuromuscular disease. The principal investigator has completed his residency training in Neurology and a clinical fellowship in neuromuscular disease. He now will continue to develop his scientific skills through studies involving transgenic mouse models and novel therapeutic agents for myotonic dystrophy type 1 (DM1). Through these experiences the applicant is expected to transition to independence by the completion of this Award. His mentoring team includes experts in neuromuscular disease, experimental therapeutics, molecular genetics, and muscle physiology. His environment and advisory team will expose the applicant to cutting edge thinking and guidance on developing treatments for muscle disease. His area of investigation, DM1, is poised to become a paradigm for translation of molecular pathophysiology into disease-modifying agents. Indeed, the applicant had the leading role in developed a novel approach that has already demonstrated impressive restorative capability in mouse models of DM1, and has potential to translate rapidly into "first in man" applications. In Aim 1 of this proposal the applicant will establish and characterize new lines of "therapy reporter" transgenic mice, i.e., mice that are specifically designed to allow rapid and precise determination of therapeutic effects through in vivo imaging. The goal is to streamline the development process. In Specific Aims 2 and 3 the applicant will further evaluate a novel use of therapeutic oligonucleotides that act through inhibition of a deleterious RNA-protein interaction. The Department of Neurology at the University of Rochester provides an ideal setting for the training of physician-scientists by incorporating expertise from clinical and basic science investigators. Such an environment maximizes the potential for the principal investigator to establish a scientific niche from which an academic career can be constructed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prospective study in myotonic dystrophy to determine extracellular RNA biomarkers
-
批准号:10837286
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2023
-
负责人:Thurman M Wheeler
-
依托单位:
Synthetic biomarkers of RNA modulation therapies
-
批准号:8841572
-
项目类别:
-
资助金额:$36.88万
-
财政年份:2014
-
负责人:Thurman M Wheeler
-
依托单位:
Synthetic biomarkers of RNA modulation therapies
-
批准号:9099988
-
项目类别:
-
资助金额:$36.55万
-
财政年份:2014
-
负责人:Thurman M Wheeler
-
依托单位:
EXPERIMENTAL THERAPEUTICS IN MOUSE MODELS OF MYOTONIC DYSTROPHY
-
批准号:8887419
-
项目类别:
-
资助金额:$0.53万
-
财政年份:2008
-
负责人:Thurman M Wheeler
-
依托单位:
EXPERIMENTAL THERAPEUTICS IN MOUSE MODELS OF MYOTONIC DYSTROPHY
-
批准号:7695032
-
项目类别:
-
资助金额:$16.05万
-
财政年份:2008
-
负责人:Thurman M Wheeler
-
依托单位:
EXPERIMENTAL THERAPEUTICS IN MOUSE MODELS OF MYOTONIC DYSTROPHY
-
批准号:8307906
-
项目类别:
-
资助金额:$16.76万
-
财政年份:2008
-
负责人:Thurman M Wheeler
-
依托单位:
EXPERIMENTAL THERAPEUTICS IN MOUSE MODELS OF MYOTONIC DYSTROPHY
-
批准号:7905693
-
项目类别:
-
资助金额:$16.21万
-
财政年份:2008
-
负责人:Thurman M Wheeler
-
依托单位:
EXPERIMENTAL THERAPEUTICS IN MOUSE MODELS OF MYOTONIC DYSTROPHY
-
批准号:7574666
-
项目类别:
-
资助金额:$15.9万
-
财政年份:2008
-
负责人:Thurman M Wheeler
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: